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Multicompartment urea kinetics in well-dialyzed children. mum delivered Kdt/V of 1.2 [1]. Extrapolation from adult
Background. We have reported catch-up growth with hemo- studies may be problematic, as more appropriate pediat-
dialysis (HD) of approximately 15 hours/week. Without an ric outcome measures—such as growth, school perfor-equilibrated post-treatment blood urea nitrogen, the variable-
mance, or pubertal development—might lead to veryvolume single-pool (VVSP) model will not account for urea
different conclusions as to the relative importance ofrebound, inflating the estimated HD dose (Kdt/V). A two-pool
model (FVDP) predicts rebound, but requires fixed compart- the small molecular weight toxins for which urea is a
ment volumes for the equations to be solvable in closed form, surrogate marker. Prior to the introduction of recombi-
also inflating Kdt/V. nant human growth hormone (rhGH), the mean annualMethods. We developed an approximate perturbation solu-
loss in height standard-deviation score (DHSDS) in pre-tion (WKB method) to a variable volume, two-pool (VVDP)
pubertal HD patients was 20.4 to 20.8 SD/year [2].model. Estimated model parameters were compared with the
results of equilibrated kinetic studies using measured clearance However, we have recently described normal growth
Kd (N 5 17). Once the model was validated, we re-analyzed rates, catch-up growth, and normal puberty with inten-
292 kinetic studies from our earlier cohort, which was consid- sive nutritional support and HD clearance in prepubertalered well-dialyzed on the basis of growth rates (N 5 12, mean
patients treated without rhGH [3]. With a weekly treat-annual change in height standard deviation score 10.31, mean
ment time of approximately 15 hours and a single-poolfollow-up of 26 months).
Results. For the VVSP, FVDP, and VVDP models, respec- urea Kdt/V of approximately 2.0, the mean annual
tively, the mean errors were (1) Kdt/V, 0.22 6 0.07, 0.29 6 DHSDS was .10.3 SD/year, and predicted final adult
0.17, 0.06 6 0.07 (ANOVA, P , 0.001); (2) urea distribution height fell generally within 2 SD of genetic potential.volume vol/wt (%), 28.2 6 4.2, 29.1 6 3.0, 22.2 6 3.6 (P ,
The standard variable-volume, single-pool (VVSP)0.001). Sequential studies confirmed reproducibility, with a co-
urea kinetic model recommended for this purpose is alsoefficient of variation #5%. In the earlier cohort, a comparison
of the VVSP and VVDP models yielded the following: (1) less satisfactory in children, predicting higher than observed
Kdt/V, 1.91 6 0.35 vs. 1.76 6 0.33 (P , 0.001); (2) normalized blood urea nitrogen (BUN) concentrations during dial-
protein catabolic rate (nPCR, g/kg/day), 1.56 6 0.39 vs. 1.52 6 ysis and failing to account for postdialysis urea rebound,0.38 (P , 0.001); and (3) Kd (whole blood, mL/kg/min), 4.8 6
felt to reflect treatment-induced compartment effects0.9 vs. 4.4 6 0.8 (P , 0.001).
[4–7]. The net result is that dialysis appears spuriouslyConclusion. This VVDP model yields reliable estimates of
Kdt/V and other kinetic parameters using standard blood urea more effective, with overestimation of dialyzer clearance
nitrogen sampling. Analysis of patients previously character- Kd, reduction in apparent urea distribution volume V,ized as well-dialyzed on the basis of growth rates clarifies the and attendant inflation of urea Kdt/V. Although fullyHD dose needed to sustain normal growth.
equilibrated (1 hour) post-treatment BUN samples will
avoid these pitfalls, this was not felt to be practical on
a routine basis [1].Based largely on adult studies correlating hemodialysis
A multicompartmental model with intracellular (ICF)(HD) mortality and morbidity with small solute clearance
and extracellular (ECF) fluid spaces in series does pre-(urea Kdt/V), the 1997 Dialysis Outcome Quality Initiative dict intercompartmental disequilibration and urea re-(DOQI) recommended monthly urea kinetic studies in
bound, but fixed compartment volumes are typically as-children receiving maintenance HD, suggesting a mini-
sumed to permit closed-form solutions (that is, formulae
predicting BUN as a function of time and other parame-
ters) [8, 9]. If used to estimate unknown model parame-Key words: hemodialysis, growth, pediatric urea kinetics, two pool
model, solute clearance, molecular toxins, blood urea nitrogen. ters, this approach leads to more egregious errors than
the single-pool model, particularly in smaller patientsReceived for publication February 10, 2000
with significant interdialytic weight gain. Although theand in revised form April 21, 2000
Accepted for publication April 28, 2000 differential equations are readily formulated for more
realistic models and even integrated numerically for in-Ó 2000 by the International Society of Nephrology
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Table 1. Clinical data and abbreviated blood urea nitrogen kinetic studies were performed (mean treatment dura-
(BUN) profiles
tion of 283 6 27 min), with patients 1 and 2 furnishing
Patient Weight Qf Td C0 C1 C1eq Kd Kr duplicate studies separated from the initial assessment
1 30.6 1.3 300 13.1 1.5 1.8 176 0.0 by three and six months, respectively. Published data
30.8 5.1 294 29.8 3.0 3.8 178 0.0 were reanalyzed for six historical cases, included because
2 46.0 2.0 300 15.7 2.4 2.9 181 0.0
of a relatively short treatment duration (142 6 30 min)44.6 3.7 300 18.5 3.1 3.8 180 0.0
3 66.8 0.8 240 12.5 2.9 3.3 217 9.0 [5, 6]. Dialyzer urea clearance Kd (whole blood, mL/min)
4 50.4 5.3 300 12.2 1.7 2.1 201 0.0 was measured by the AV gradient method (a detailed
5 18.0 0.4 240 18.8 8.2 9.2 37 3.8
explanation and equations are in the Appendix, Equa-6 36.1 5.8 240 14.1 3.1 3.5 208 1.6
7 65.0 7.3 300 21.5 5.0 5.4 233 3.4 tion 1, which can be found on the web site: http://dx.doi.
8 34.0 5.0 300 21.4 2.4 2.8 206 0.0 org/10.1046/j.1523-1755.2000.58-2138.s). The blood pump9 30.2 4.0 300 34.6 3.9 4.7 181 0.0
was calibrated prior to each study, and a commercial10 15.0 1.7 173 10.7 3.3 3.8 72 0.0
11 31.2 4.9 182 10.9 4.3 5.3 101 1.6 indicator-dilution technique was used to measure blood
12 18.8 1.9 105 7.4 4.3 4.7 61 0.6 flow and exclude access recirculation (Transonic Systems13 11.2 0.8 126 6.3 2.1 2.4 61 0.0
Inc., Ithaca, NY, USA) [11], the latter corroborated in14 24.3 4.3 140 13.6 5.7 6.7 102 0.6
15 21.7 4.9 123 8.2 3.9 4.8 89 0.0 each case by the multiple-BUN method (Equation 2).
Profiles are from 17 equilibrated kinetic studies used for validation of the BUN sampling (mmol/L, whole blood) was typically
variable volume, two compartment model. Abbreviations are: pre- (C0), post- hourly from the inlet side of the dialyzer during treat-(C1), and equilibrated (C1eq) BUNs (mmol/L, whole blood); dialysis duration (Td,
min); measured dialyzer clearance Kd (mL/min, whole blood); ultrafiltration rate ment (“slow-flow” technique [1]) and included predial-
(Qf, mL/min); residual renal urea clearance (Kr, mL/min); weight (post-dialysis, kg). ysis (C0), end-dialysis (C1), equilibrated one-hour postdi-
alysis (C1eq), and a second predialysis sample (C2) before
vestigational purposes, closed-form solutions are usually the next treatment. The end-dialysis specimen was drawn
not possible, hindering routine application in a clinical five minutes after the dialysate flow stopped. Residual
setting. In the physical sciences, perturbation methods renal urea clearance Kr (mL/min) was calculated from
are often used to formulate approximate closed-form interdialytic urine collections, and ultrafiltration rates
solutions to otherwise intractable differential equations (Qf, mL/min) were based on pre-treatment and post-
[10]. These solutions rely on identification of “small” treatment weights. For the historical cases [10–15], pub-
parameters in the governing equations and are typically lished data, including C0, C1, C1eq, and midtreatment (Cs)expressed as the solution to the simpler, solvable system BUNs, dialysis duration (Td, min), Kd, Qf, Kr, weight,in which these quantities are neglected (the unperturbed
and recirculation status [5, 6].
model) plus a correction term (perturbation).
The VVDP model is illustrated in Figure 1. In contrastHere, we reformulated a two-compartment, variable-
to the single-pool model, total body water consists ofvolume model (VVDP). A straightforward perturbation
distinct intracellular and extracellular compartments,expansion yielded the VVSP model as unperturbed solu-
with Kei 5 intercompartmental urea mass transfer areation plus a correction term incorporating the effects of
coefficient (the caption in Fig. 1 defines the variables).finite intercompartmental urea permeability. This solu-
The key assumptions and derivation of the perturbationtion fitted well with the experimental data and furnished
solution (Wentzel-Kramer-Brillouin method) are de-reliable estimates of equilibrated kinetic parameters in
tailed in the Appendix, where Equation 9 predicts ureatypical pediatric HD studies. We then retrospectively
concentration as a function of time and other parameters.reanalyzed 292 monthly urea kinetic studies collected
This general solution contains constants related to bothon the prepubertal patients from our earlier report of
the compartment and interval being modeled. Amonggrowth, felt to be unequivocally well-dialyzed on the
these alternate forms, the most useful clinically predictsbasis of growth rates and pubertal development. These
data furnished an estimate for the dialysis dose needed extracellular (blood) urea concentrations during dialysis,
to sustain normal growth and development. used by the curve fitting algorithm to estimate Kd, V, and
Kdt/V on the basis of intradialytic BUNs. Specializing
Equation 9 for these conditions:METHODS
The 12 patients described in our earlier report, all







HD in our center from 1991 until the introduction of
rhGH in 1997, are fully characterized, including details of
diagnosis, treatment, nutritional supplements, metabolic
3 1Ve[0] 2 QftVe[0] 2
K1Kei2Qf
Qf 1 Vt[0]Vt[0] 2 Qft2
K
Qf
control, routine urea kinetic studies, and growth, in Tom
et al [3]. Validation of the VVDP model involved 15
patients (Table 1). From our unit, 11 equilibrated urea k1 5 C0 2 Css 2 k2
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Fig. 1. Variable-volume, two-compartment urea
kinetic model. Abbreviations are as follows: Vi,
intracellular fluid (ICF) volume; Ci, ICF urea
concentration; Ve, extracellular fluid (ECF)
volume; Ce, ECF urea concentration; Kei, inter-
compartmental urea mass transfer area coeffi-
cient; f, fraction of ultrafiltrate from ICF; Kr,
residual renal urea clearance; G, urea genera-
tion rate; Qf, ultrafiltration rate (.0) or interdi-
alytic weight gain (,0); Kd, dialyzer urea clear-
ance. In the dialyzer-access circuit, flows (Q)
and concentrations (C) refer to peripheral
blood (p), dialyzer inlet (bi), dialyzer outlet
(bo), and access recirculation (r). For nota-
tional convenience, K 5 Kd 1 Kr, Ce[0] 5 C0,
Ce[¥ ] 5 Css 5 G/(Kd 1 Kr 2 Qf), and Vt 5
Ve 1 Vi. Concentrations, flows, and Kd here
refer to blood water (whole blood C/0.93, 0.9
whole blood Q or Kd).
dialysis prescription changes in the previous week), the
results of two-BUN (steady-state) and three-BUN sam-k2 5
(G 2 C0(K 2 Qf))Vi2
Vi(QfVi 2 K(Vi 2 Ve[0])) 2 KeiVt[0]2 pling were formally compared as described in the Appen-
dix. Pre-treatment and end-treatment BUNs were col-Note that in the limit Kei ! ¥ (that is, 1/Kei ! 0),
lected for a two-week period (7 consecutive treatmentsk2 ! 0, the perturbation term multiplying k2 vanishes,
for all but patient 9, in whom only 4 consecutive studiesand this expression reduces to the unperturbed VVSP
were obtained due to a schedule change). In addition,model. Analogous expressions for the ICF and interdia-
Kd, blood flow, and recirculation were measured at thelytic interval also follow from Equation 9. For each of
outset and used to establish urea volume V. Blood flowthe VVSP, FVDP, and VVDP models, estimates of V
was verified with each treatment. For the retrospectiveand G (Kd specified by the user) or Kd and G (V specified)
analysis in Table 5, anthropometric estimates of totalare obtained by iterative methods, minimizing the dis-
body water based on gender and height were suppliedcrepancy between observed and predicted BUN, as de-
to estimate Kd [17].scribed in the Appendix. Calculation of Kdt/V used blood
The DOQI advises that residual renal clearance bewater Kd, and protein catabolic rate (PCR) was calcu-
expressed as the equivalent dialyzer clearance needed tolated by the Borah equation (PCR 5 0.262 3 G 1
replace Kr and maintain the same predialysis BUN [1].0.294 3 V, for G in mmol/min, V in L, and PCR in g/day)
In practice, it may be approximated by (Kt/V)renal 5 kand normalized to V/0.58 (nPCR) [12]. The errors associ-
Kr /V, with k 5 5.5 for three times weekly dialysis andated with the various models are expressed relative to
6.5 for twice weekly dialysis (Kr in mL/min, V in L)the reference values from the single-pool analysis with
[18, 19]. To evaluate k in children modeled with themeasured Kd and equilibrated postdialysis BUN (C1eq).
VVDP, we simulated symmetric dialysis schedules (3, 4,For both two-pool models, intercompartmental urea
or 5 weekly treatments, for a total of 15 hours/week) inmass transfer Kei was assumed to be approximately 10
four typical pediatric scenarios (weights 15, 30, 45, 60 kg;mL/min/kg [5, 6, 13], and the ratio of extracellular to
Qf 5 90 mL/kg/week; C0 5 25 mmol/L; and G 5 3 mmol/intracellular volume (Ve/Vi) at dry weight was assumed
kg/min). Kd was then systematically varied from 2 to 5.5to be approximately one third [14]. The Smye method
mL/min/kg, and Kr was varied from 0 to 6 mL/min/1.73predicts C1eq based on intradialytic samples (C0, Cs, C1);
m2. Each value of k was calculated from 42 to 46 analyses,the predicted value is then used with the VVSP to esti-
where Kr was set to zero and Kd adjusted to maintainmate equilibrated parameters [6, 15]. The Daugirdas rate
the same predialysis urea concentrations.equation furnishes a semiempiric estimate of equili-
Data are mean 6 1 SD. All models were implementedbrated Kdt/V based on the standard single-pool result
with Mathematica 4.0 (Wolfram Research, Champagne,and dialysis duration Td [16].
IL, USA). For the VVSP and VVDP, a C language Add-For patients 2, 4, 7, 8, and 9, deemed to be in a clinical
steady state (no intercurrent illnesses and no dietary or In for Microsoft Excel (Redmond, WA, USA) is also freely
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Fig. 2. Kdt/V error and dialysis duration: DKdt/V 5 error caused by
unequilibrated single-pool analysis. Long treatment duration (s; N 5
11) was 283 6 27 minutes compared with six historical controls dialyzing
for 142 6 30 minutes (e).
available from the author (A.S.). Statistical analysis was Fig. 3. Predicted blood and intracellular urea concentrations (patient
performed using SAS 6.12 (SAS Institute, Durham, NC, 9) using measured Kd with equilibrated single-pool (“true”) urea distri-
bution volume and urea generation rate. Actual BUN (d) was sampledUSA). Mean errors relative to reference values were
at the dialyzer inlet during treatment, with an equilibrated peripheralcompared by one-way analysis of variance (ANOVA), sample drawn at one-hour postdialysis. Abbreviations are: VVSP, vari-
with significant group differences (P , 0.05) localized by able volume, single-pool model; VVDP, variable volume, double-pool
model; Ci, intracellular urea (mmol/L); Ce, extracellular urea (mmol/L).post hoc application of the pairwise least significant differ-
Symbols are: (heavy line) VVDP Ce; (thin line) VVDP Ci; (dashed line)ence test. Confidence intervals on the discrepancy between VVSP C.
different estimates of the same parameter are calculated
as Bland–Altman 95% limits of agreement [20].
nificantly underestimated urea distribution volume V
RESULTS compared with the VVDP (22.2 6 3.6% body wt). The
Figure 2 illustrates the error in estimation of true equil- group difference was significant (ANOVA, P , 0.001)
ibrated Kdt/V when the unequilibrated, end-dialysis and localized to the comparison of VVDP with VVSP
BUN was used with the VVSP model. The 11 kinetic (P 5 0.002) and FVDP (P , 0.001). As a consequence,
studies performed in our dialysis unit (treatment dura- both the unequilibrated VVSP and FVDP models over-
tion 283 6 27 min) were compared with the six historical estimated Kdt/V to a comparable degree. When the Smye
cases with a treatment duration of 142 6 30 minutes. method was used to predict the equilibrated post-treat-
Despite different dialysis regimens, there was a compara- ment BUN, the mean Kdt/V error was less, but the vari-
ble degree of overestimation in Kdt/V in the two groups ability was higher, resulting in wider 95% limits of agree-
ment. The rate equation and the VVDP model had(0.22 6 0.07, range 0.14 to 0.32, vs. 0.21 6 0.07, range
0.12 to 0.29, P 5 0.77). similar smaller errors (20.03 6 0.06 vs. 0.06 6 0.07) and
narrower limits of agreement. Once again, ANOVA P ,Reference (“true”) values for Kd, V, and G were ob-
tained by direct measurement of Kd with access recircula- 0.001 and post hoc comparisons confirmed that both
the VVDP and rate equation errors were significantlytion excluded. Kd, in turn, furnished the equilibrated
single pool estimates of V and G. As shown in Figure 3 smaller than the unequilibrated VVSP (P 5 0.002) and
FVDP (P , 0.001) results.(patient 9), these values may be used to generate pre-
dicted blood (ECF) or ICF urea profiles for the various Without a second predialysis BUN for the historical
cases, estimation of G and PCR involved only the 11models. During treatment, BUN predicted by the stan-
dard VVSP model was consistently higher than that ob- studies performed in our unit. In both cases, the VVSP
estimates were associated with a larger errors than theserved and failed to reproduce postdialysis urea rebound.
The FVDP model (data not shown) also predicted higher VVDP. For G, the mean errors were 28.4 6 3.6 versus
22.6 6 5.8 mmol/min, respectively (paired t, P 5 0.01).than observed intradialytic BUN, particularly late in dial-
ysis. As shown here, the VVDP model predicted both For PCR, errors were 22.9 6 1.0 versus 20.8 6 1.6 g/day
(P 5 0.005). In the calculation of nPCR, underestimationintercompartmental urea disequilibration and the post-
treatment rebound phase, with a better fit to the ob- of V by the VVSP will partially offset this error, with a
mean discrepancy of 0.06 6 0.05 g/kg/day compared withserved data likely to yield improved parameter estimates.
Table 2 compares reference values from the equili- 0.02 6 0.05 g/kg/day for the VVDP (P 5 0.09).
Reproducibility of parameter estimates was assessedbrated single-pool model with estimates derived from the
VVSP, FVDP, VVDP, Smye method, and rate equation by sequential studies in five patients deemed to be in a
clinical steady state, with no intercurrent illness and nousing standard pretreatment and end-treatment BUN.
Both the unequilibrated VVSP and FVDP models sig- diet or dialysis schedule change in the previous week.
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Table 2. Comparison of modeled parameter estimates
VVSPeq Error VVSP FVDP Smye VVDP Rate
Vol/wt % 59.767.5 mean 28.264.2 29.163.0 24.568.5 22.263.6
95% limits 216.4–0 215–3.1 221.1–12.1 29.2–4.8
Kdt/V 1.5760.68 mean 0.2260.07 0.2960.17 0.1160.26 0.0660.07 20.0360.06
95% limits 0.09–0.35 20.04–0.62 20.39–0.62 20.08–0.19 20.16–0.10
Mean errors (6 SD) and 95% limits of agreement for urea distribution volume V and Kdt/V (N 5 17). Abbreviations are: VVSP, variable volume, single-pool
model with standard end-treatment BUN (C1); VVSPeq, reference values from VVSP with equilibrated post-treatment BUN (C1eq); FVDP, fixed volume, two-pool
model with C1; Smye, VVSP with C1eq predicted by Smye method; VVDP, variable volume, two pool model with C1; Rate, estimate of equilibrated Kdt/V by the
Daugirdas rate equation.
Table 3. Comparison of two BUN (steady-state) and three BUN kinetics studies
Vol/wt % Kd mL/min/kg Kdt/V G lmol/min nPCR g/kg/day
Mean6SD 61.969.6 4.560.3 2.2160.43 161644 1.1460.43
Two BUN CV % 5.762.1 3.360.8 5.462.1 8.463.8 9.562.6
Three BUN CV % 5.261.0 3.460.7 5.662.4 13.862.7 12.362.5
95% Limits 23.0–3.5 20.03–0.06 20.15–0.13 219–21 20.15–0.15
Reproducibility is reported as intrasubject coefficient of variation (CV, %). Bland-Altman 95% limits of agreement are calculated on the discrepancies between
the two methods. Abbreviations are: Vol/wt, urea distribution volume as fraction of post-dialysis weight (%); Kd, whole blood dialyzer clearance (modeled) mL/
min/kg; Kdt/V, treatment21; G, urea generation rate (mmol/min); nPCR, normalized protein catabolic rate (g/kg/day).
Table 4. Proportionality constant for estimation of (Kt/V)renalTable 3 shows the intrasubject coefficient of variation
for the two-BUN (N 5 32) and three-BUN (N 5 27) Kdt/V 33/week 43/week 53/week
studies. The variation in modeled values of V, Kd and 0.6 1.9
0.8 2.8 2.0Kdt /V are approximately 5% or less by either method.
1.0 4.7 3.0 2.0Discrepancies between the two methods (mean 6 SD)
1.2 5.2 3.2 2.1
were small for V as a proportion of postdialysis weight 1.4 5.9 3.4 2.3
1.6 6.9 3.7(0.2 6 1.7%), whole blood Kd (20.01 6 0.02 mL/kg/
1.8 7.3 4.1min), and Kdt/V (20.01 6 0.07). For Kdt/V, the 95% 2.0 9.1 4.6
agreement interval (based on 27 paired comparisons)
Proportionality constant for estimation of (Kt/V)renal 5 kKr/V as a functionwas 20.15 to 0.13. Intrasubject variations in G and nPCR of dialysis frequency and dialyzer clearance (Kr in mL/min, V in liters). Each k
value is based on 42 to 46 simulations.are larger, 12 to 14% for the three-BUN method and 8
to 10% for the steady-state analysis. Since the two meth-
ods do not reflect the same interdialytic intervals, only
average values of G and nPCR may meaningfully be com- We retrospectively re-analyzed 292 monthly studies
pared [18], and moving averages (r 5 3) were calculated collected on the 12 prepubertal patients described in our
before assessing agreement. The discrepancy between earlier report [3]. Our treatment regimen consisted of
methods was 20.9 6 10.3 mmol/min for G and 0.0 6 14.8 6 1.8 hours per week of HD, three times weekly,
0.07 g/kg/day for nPCR, with 95% limits of agreement except as noted in Table 5, and recommended nutritional
between 20.15 to 0.15 for the latter, based on 17 paired intake (RNI) for energy and protein. The latter was
comparisons. achieved with supplements, gavage feeds, and intradia-
In practice, (Kt/V)renal , k · Kr /V, where k is deter- lytic parenteral nutrition. Compared with RNI promoted
mined by formal kinetic modeling based on the notion by the American Dietetics Association for children on
of equivalent dialyzer clearance needed to replace Kr and HD [21], the mean intake was 91% for calories and 156%
achieve the same predialysis urea concentrations [1, 18, 19]. for protein. The urea reduction ratio (URR) was 84.7 6
Table 4 displays k values obtained with the VVDP model 4.9%. Despite earlier reports associating obesity with at-
as weight (15 to 60 kg), Kd (2 to 5.5 mL/min/kg), Kr (0 to 6 tempts to supplement calories beyond 70 to 80% RNI [22],
mL/min/1.73 m2), and weekly schedule (3 to 5 treatments/ no overt obesity was observed by conventional criteria.
week) were systematically varied. For a given treatment Table 5 compares the unequilibrated VVSP and VVDP
frequency and dialyzer Kdt/V, the linear approximation estimates of dialyzer Kdt/V (treatment21), normalized PCR
continued to hold for the two-pool model, with all R2 . (g/kg/day), and modeled dialyzer clearance Kd (whole
0.94. As with the VVSP (data not shown), there was a blood, mL/min/kg). All three kinetic parameters were
striking dependence on dialyzer clearance, with k 5 4.7 significantly smaller in the two-pool analysis (paired t,
P , 0.001). Estimated (Kt/V)renal using the equivalencewhen Kdt/V 5 1.0 and k 5 9.1 when Kdt/V 5 2.0.
Sharma et al: Pediatric urea kinetics 2143
Table 5. Patients characterized as well-dialyzed based on growth rates
Patient Age DHSDS/year URR % (Kdt/V)sp nPCRsp (Kd)sp (Kdt/V)dp nPCRdp (Kd)dp (Kt/V)renal
1a 5 1.42 86.8 2.00 2.00 5.8 1.83 1.92 5.2 0.18
2 12 0.50 77.7 1.48 1.28 4.2 1.34 1.24 3.8 0.95
3 14 0.25 80.4 1.55 0.94 4.0 1.42 0.90 3.7 0.18
4 5 0.16 85.8 2.12 1.54 4.8 1.97 1.50 4.5 0.00
5 10 0.52 84.0 1.77 1.78 4.0 1.65 1.73 3.7 0.56
6 5 0.41 85.1 1.80 1.26 5.1 1.63 1.21 4.6 0.21
7b 5 0.00 92.9 2.60 2.27 6.8 2.40 2.24 6.3 0.10
8c 7/12 0.05 91.4 2.25 1.50 5.4 2.08 1.48 5.0 0.00
9 10 20.32 88.4 2.24 1.80 5.5 2.07 1.74 5.0 0.03
10 12 0.41 85.1 1.92 1.58 4.2 1.80 1.54 3.9 0.00
11 7 0.37 81.7 1.70 1.76 3.8 1.59 1.71 3.6 0.00
12 12 20.04 77.1 1.48 1.06 4.3 1.34 1.01 3.9 0.00
mean 0.3160.43 84.764.9 1.9160.35 1.5660.39 4.860.9 1.7660.33d 1.5260.38d 4.460.8d 0.1860.29
Monthly kinetic studies (N 5 292) from 12 patients previously characterized as well dialyzed based on normal growth rates and pubertal development (mean
follow-up 26 months). Abbreviations are: age, years at start of HD; DHSDS, mean annual change in height standard deviations score; URR, urea reduction ratio;
sp, VVSP; dp, VVDP; nPCR, g/kg/day; Kd, whole blood mL/min/kg (modeled); Kdt /V, treatment21, (Kt /V)renal, renal Kt /V as equivalent dialyzer clearance from Table 4.
Dialysis was thrice weekly except as noted, with the mean number of weekly treatments during the study period indicated by: a 3.6, b 4.3, c 3.2.
dP , 0.001 (paired t, VVSP vs. VVDP)
relationships defined in Table 4 is also shown. Total Kt/V to children is one issue. The pediatric literature has em-
phasized age-appropriate outcome measures, particu-(dialyzer 1 residual renal, treatment21) was 2.10 6 0.35
(range 1.48 to 2.73) for the VVSP model versus 1.95 6 larly growth and development [2, 22, 33]. There has also
been long-standing concern with overestimation of dial-0.34 for the VVDP (range 1.34 to 2.53, P , 0.001). The
delivered (modeled) Kd was 4.4 6 0.9 mL/min/kg ysis dose in children by the standard VVSP model, which
cannot account for the compartmental effects illustrated(VVDP) versus 4.8 6 0.9 (VVSP, P , 0.001), and nPCR
in Figure 3 [4–7]. More complex models have provenwas 1.52 6 0.38 (range 0.9 to 2.2 g/kg/day).
useful for investigational purposes, but a lack of closed-
form solutions and the number of parameters requiring
DISCUSSION a priori estimates make them less practical in a clinical
Urea is regarded as a surrogate marker for small, dia- setting [34]. There have been several ingenious ap-
lyzable toxins derived from protein metabolism. In isola- proaches to closed-form solutions that reflect the multi-
tion, blood concentrations are poor outcome predictors compartmental nature of urea distribution and are more
[23]. However, for a given PCR (approximately steady- suitable for iterative curve fitting. The FVDP model also
state protein intake), the National Co-operative Dialysis spuriously inflates apparent dialyzer clearance. Smye
Study (NCDS) identified the time-averaged urea concen- adapted it with a prediction formula for the equilibrated
tration (TAC) as the most powerful predictor of treat- post-treatment BUN based on intradialytic samples [6].
ment failure (death or hospitalization) [24, 25]. Time on It requires an additional BUN midtreatment, precluding
dialysis—a surrogate for “middle molecule” clearance, analysis of previously collected studies, and the resulting
which is less responsive to increased flow rates—was a estimate had a wide confidence interval, confirming a
significant but less powerful discriminator (hospitaliza- recent pediatric comparison [35].
tion) [24, 26]. A “mechanistic” re-analysis of the NCDS Unlike this series arrangement of ICF and ECF com-
data introduced urea Kdt/V, the number of times the partments, an alternate model with two parallel pools has
total body water was cleared of urea per treatment, and also been proposed, in which urea sequestration occurs in
a measure of delivered dialysis dose when derived from poorly perfused organs, such as bone, skin, and muscle
kinetic modeling [27]. Prospective trials have subse- [16, 36]. The two approaches are mathematically equiva-
quently confirmed the relationship between Kdt/V and lent, with Kei replaced by QL, the fraction of cardiac
uremic symptoms, particularly anorexia [28], and urea output to the low perfusion compartment [37]. The
kinetics are widely used to identify discrepancies between model predicts that Kdt/V overestimation will be aggra-
delivered and prescribed HD dose [29, 30]. More recently, vated by shorter treatment duration (Td) and increased
dialysis efficiency (Kd /V). Consequently, the rate equa-it has been suggested that Kdt/V in the range not exam-
ined by the NCDS might further reduce mortality [31], tion estimates equilibrated Kdt/V from the standard sin-
gle-pool result and Td. As shown here and in the compari-prompting a controlled, randomized trial with single-
pool Kdt/V of 1.2 versus 1.6 [32]. son by Marsenic, Peco-Antic, and Jovanovic [35], this
semiempiric approximation furnishes an excellent esti-Comparable data in children are lacking. Concern
about applicability of the NCDS definition of adequacy mate of equilibrated Kdt/V in pediatric HD. Although
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the rate equation predicts that overestimation of Kdt/V and nPCR suggests that this is equally true in children.
Because of study-to-study variability, it is important toby the VVSP model will diminish as treatment is pro-
longed, the absolute error in our patients with almost consider only mean values for G and nPCR from repeat
studies when making prescription changes. With this pro-five hours of dialysis is comparable to that observed in
the cases dialyzing for half as long and is likely to be viso, agreement between the two methods was again
satisfactory, although the three-BUN method is the onlyclinically significant in some (range 0.14 to 0.32).
The proposed VVDP model is highly idealized, and option when the steady-state assumption does not hold.
The notion of equivalence used to define the contribu-the solution in Equation 9 is an approximate one (Ap-
pendix). Still, it accurately predicts observed blood urea tion of residual renal clearance (Kt/V)renal in terms of
dialyzer clearance required to replace it and achieve theconcentrations and reproduces the key treatment-induced
compartmental effects. This good fit with observed data same blood urea concentrations is widely recognized. It
is based on the NCDS conclusion that for a given PCR,permits reliable estimates of equilibrated kinetic param-
eters using standard predialysis and end-dialysis BUNs. blood urea concentration is the most important predictor
of outcome [1, 18, 19, 25]. Although there are few compa-Although it neglects osmotic flux, sodium ramping be-
tween 140 and 150 mmol/L in our unit did not appear rable pediatric data, measuring renal clearance consis-
tently is a prerequisite for carrying out such studies. Anto influence the goodness of fit. It is also parsimonious
in terms of additional parameters requiring a priori esti- approximation scheme (k Kr /V, k 5 5.5 for three times
weekly dialysis) also appears reasonable for what is, aftermates, with only two beyond those of the VVSP: (1)
whole body urea mass transfer coefficient Kei and (2) the all, a rough estimate. As with the single-pool model in
adults, k varies with both dialysis frequency and achievedratio of ECF to ICF volume at dry weight. In adults, the
former is approximately 800 mL/min/1.73 m2 [reviewed Kdt/V, since lower post-treatment BUN permits the same
residual renal function to maintain lower blood urea con-in 13]. Similar values have been reported from careful
analysis of urea rebound in six pediatric patients [5, 6]. centrations. The tabulated results may also be used with
the single-pool model or rate equation estimates whereFor the latter, we adopt a value of one third [14].
The intrasubject variation in kinetic parameters in Ta- target Kdt/V exceeds 1.1 or where fluid and other consid-
erations mandate a more frequent dialysis schedule.ble 3 is similar to the results of single-pool modeling in
children [38]. This reproducibility of vol/wt is of clinical Given the paucity of pediatric data relating outcome
to delivered dialysis dose, re-analysis of our prepubertalutility: The current practice in our dialysis unit is to
measure Kd and recirculation fraction concurrently in cohort was thought warranted to furnish a better esti-
mate of the dialysis dose needed to sustain normalthree different treatments. The measured clearance may
be corrected for access recirculation with Equation 3 growth. Even if the NCDS experience can be extrapo-
lated directly to uniquely pediatric manifestations of ure-(Appendix). Measured Kd is then used with the VVDP
model to estimate V, with its mean value used to fit Kd mia, their recommendations were based on a protein
intake of #1.1 g/kg/day, which represented an inflectionin subsequent studies. Alternatively, the physician may
estimate Kd based on flow rates and measured dialyzer point on the therapy target modeling line. Above this, the
target line begins to cross Kt/V isopleths in an upwardurea mass transfer KoA [1]. This can be used to fit V, with
changes in the latter from baseline identifying technical direction [27], an important consideration given current
guidelines from the American Dietetics Association forproblems with dialysis. The two approaches are equiva-
lent, and we prefer to interpret Kd directly. Kdt /V is children on HD (ranging from 3.3 g/kg/day for infants
to 1.3 to 1.5 g/kg/day in teenagers) [3, 21]. Even thoughlargely unaffected by this choice, since errors in Kd and
V tend to be proportional. anabolism in growing children will contribute to a dis-
crepancy between dietary protein intake and PCR, thisIn adults, abbreviated two-BUN (steady-state) sam-
pling may be preferable to the three-BUN method, since is small (,0.05 g/kg/day) even during periods of rapid
growth [40, 41]. As these kinetic studies confirm, proteinit is more easily performed, less dependent on a single
interdialytic interval, and less prone to patient manipula- catabolism exceeded the NCDS standard (nPCR 1.52 6
0.38, range 0.9 to 2.2 g/kg/day), and increased dialysistion of a study in progress [39]. As shown here, the two
methods produce virtually identical estimates for V, Kd, requirements might therefore be expected.
The Kdt/V estimate provided by the VVDP modeland Kdt/V. This is not unexpected, since V and Kd are
principally determined by the intradialytic urea samples, moves our dose targets closer to the norm, but the com-
bined Kt/V (1.95 6 0.34, range 1.3 to 2.5) continueswhile G and nPCR largely reflect the interdialytic kinet-
ics. By reflecting protein balance for the whole week, to exceed current guidelines. Although we attempt to
maximize blood flow and dialyzer surface area, the actualthe steady-state method is theoretically less prone to
dietary indiscretions in the single interdialytic interval dialyzer clearance (4.4 6 0.8 mL/min/kg) is considered
conventional [41, 42], which is not unexpected given thespanned by the three BUN samples. The smaller coeffi-
cient of variation for the steady-state estimates of G practical limitations in pediatric access flows and maxi-
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for the two-compartment model, in Prescribing Hemodialysis: Amally tolerated extracorporeal volumes. In fact, there
Guide to Urea Modeling, Dordrecht, Kluwer Academic Publishers,
is little experience with high-flow (“high-flux”) HD in 1991, pp 98–101
10. Lin CC, Segal LA: Regular perturbation theory, in Mathematicschildren [43], leaving time on dialysis as the principle
Applied to Deterministic Problems in the Natural Sciences, Philadel-means of augmenting clearance. We are reluctant to
phia, SIAM, 1988, pp 225–276
extrapolate our results to shorter treatment times, where 11. Krivitski NM: Theory and validation of access flow measurement
by dilution technique during hemodialysis. Kidney Int 48:244–250,small solute Kdt/V is maintained by higher flows. This
1995approach may compromise membrane-limited middle
12. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfsen
molecule clearance, which is minimally responsive to M, Humphreys MH: Nitrogen balance during intermittent dialysis
therapy of uremia. Kidney Int 14:491–500, 1978changes in flow rates. For a given TAC/PCR, time on
13. Heaf J, Simone J: Normalized cellular clearance of creatinine,dialysis (a surrogate measure of middle molecule clear-
urea, and phosphate. Nephron 67:197–202, 1994
ance) was a significant predictor of morbidity in the 14. Friis-Hansen BJ: Body water compartments in children: Changes
during growth and related changes in body composition PediatricsNCDS, albeit less powerful than TAC [26, 44]. The rela-
28:169–181, 1961tively short follow-up (6 month) also precluded apprecia-
15. Smye SW, Dunderdale E, Brownridge G, Will E: Estimation of
tion of longer term middle-molecule toxicity. Moreover, treatment dose in high-efficiency haemodialysis. Nephron 67:24–29,
1994the role of middle molecules in the pathogenesis of
16. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dosegrowth failure in children is not known.
depends on dialysis efficiency by regional blood flow but not by
We believe the experience at our center supports an conventional two pool urea kinetic analysis. ASAIO J 41:M719–
M724, 1995upward revision in dose guidelines for children. How-
17. Cheek DB, Mellits D, Elliot D: Body water, height, and weightever, a multicenter, controlled trial should address this
during growth in normal children. Am J Dis Child 112:312–317,
question prospectively and more clearly define treatment 1966
18. Gotch FA: Kinetic modeling in hemodialysis, in Clinical Dialysistargets for various ages and subsets. We hope our results
(3rd ed), edited by Nissenson AR, Fine RN, Gentile DE, Engle-and the kinetic model developed and validated here will
wood Cliffs, Prentice Hall, 1995, pp 156–189
provide a starting point for such discussions. 19. Depner TA: Residual (native kidney) urea clearance: Its signifi-
cance, in Prescribing Hemodialysis: a Guide to Urea Modeling,
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